Chicago Mercantile Exchange › (CME:K5.K12.3150P)
(0.00%)
, 10 min delay
Free Instant Analysis: Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money.
Trader's Blog
Today's Video Update: To Taper Or Not To Taper?
16 hours ago
Stocks edge lower as investors wait on Fed
17 hours ago
Crude Oil Breakout & Some Implications
20 hours ago
Fundamentals Can Kill You If You're Not Careful!
1 day ago
Today's News
Fed's moves to aid economy since financial crisis
11 hours ago
The Federal Reserve has taken many unprecedented steps in the past four years to try to boost the U.S. economy and counter the effects of a financial crisis that triggered a painful recession. It has kept the short-term interest rate it controls at a record low near zero since December 2008. Some steps the Fed has taken:
AP Top Financial News At 7:10 p.m. EDT
10 hours ago
Fed suggests it's closer to slowing bond purchases Stocks slide as Fed says bond purchases could slow Men's Wearhouse ousts founder, pitchman Zimmer
AP Top Extended Financial Headlines At 7:10 p.m. EDT
10 hours ago
Fed sticks with bond purchases but offers brighter outlook for the economy Stocks slide and Treasury yields spike after Bernanke says Fed could slow its bond purchases
Bluebird Bio shares rocket higher in trading debut
11 hours ago
Shares of gene therapy developer Bluebird Bio Inc. surged in their trading debut. Its shares climbed $9.91, or 58.3 percent, to close at $26.91 Wednesday after trading as high as $27 earlier in the session. The company's initial public offering of 5.94 million shares had been priced Tuesday at $17 per share, above its initial expectations of $14 to $16 per share.
